Sodium pyruvate reduces hypoxic-ischemic injury to neonatal rat brain

Rui Pan, Zhihui Rong, Yun She, Yuan Cao, Li Wen Chang, Wei Hua Lee

Research output: Contribution to journalArticle

24 Citations (Scopus)

Abstract

BackgroundNeonatal hypoxia-ischemia (HI) remains a major cause of severe brain damage and is often associated with high mortality and lifelong disability. Immature brains are extremely sensitive to HI, shown as prolonged mitochondrial neuronal death. Sodium pyruvate (SP), a substrate of the tricarboxylic acid cycle and an extracellular antioxidant, has been considered as a potential treatment for hypoxic-ischemic encephalopathy, but its effects have not been evaluated in appropriate animal models for hypoxic-ischemic encephalopathy.MethodsThis investigation used primary cortical neuron cultures derived from neonatal rats subjected to oxygen and glucose deprivation (OGD) and a well-established neonatal rat HI model.ResultsHI caused brain tissue loss and impaired sensorimotor function and spatial memory whereas SP significantly reduced brain damage and improved neurological performance. These neuroprotective effects of SP are likely the result of improved cerebral metabolism as demonstrated by maintaining adenosine triphosphate (ATP) levels and preventing an increase in intracellular reactive oxygen species (ROS) levels. SP treatment also decreased levels of Bax, a death signal for immature neurons, blocked caspase-3 activation, and activated a key survival signaling kinase, Akt, both in vitro and in vivo.ConclusionSP protected neonatal brain from hypoxic-ischemic injury through maintaining cerebral metabolism and mitochondrial function.

Original languageEnglish
Pages (from-to)479-489
Number of pages11
JournalPediatric Research
Volume72
Issue number5
DOIs
StatePublished - Nov 2012

Fingerprint

Pyruvic Acid
Sodium
Wounds and Injuries
Brain
Brain Hypoxia-Ischemia
Ischemia
Neurons
Citric Acid Cycle
Neuroprotective Agents
Caspase 3
Reactive Oxygen Species
Phosphotransferases
Animal Models
Antioxidants
Adenosine Triphosphate
Oxygen
Glucose
Mortality
Hypoxia

ASJC Scopus subject areas

  • Pediatrics, Perinatology, and Child Health

Cite this

Pan, R., Rong, Z., She, Y., Cao, Y., Chang, L. W., & Lee, W. H. (2012). Sodium pyruvate reduces hypoxic-ischemic injury to neonatal rat brain. Pediatric Research, 72(5), 479-489. https://doi.org/10.1038/pr.2012.107

Sodium pyruvate reduces hypoxic-ischemic injury to neonatal rat brain. / Pan, Rui; Rong, Zhihui; She, Yun; Cao, Yuan; Chang, Li Wen; Lee, Wei Hua.

In: Pediatric Research, Vol. 72, No. 5, 11.2012, p. 479-489.

Research output: Contribution to journalArticle

Pan, R, Rong, Z, She, Y, Cao, Y, Chang, LW & Lee, WH 2012, 'Sodium pyruvate reduces hypoxic-ischemic injury to neonatal rat brain', Pediatric Research, vol. 72, no. 5, pp. 479-489. https://doi.org/10.1038/pr.2012.107
Pan, Rui ; Rong, Zhihui ; She, Yun ; Cao, Yuan ; Chang, Li Wen ; Lee, Wei Hua. / Sodium pyruvate reduces hypoxic-ischemic injury to neonatal rat brain. In: Pediatric Research. 2012 ; Vol. 72, No. 5. pp. 479-489.
@article{3f39f035a46f4f95b36d167360dfb524,
title = "Sodium pyruvate reduces hypoxic-ischemic injury to neonatal rat brain",
abstract = "BackgroundNeonatal hypoxia-ischemia (HI) remains a major cause of severe brain damage and is often associated with high mortality and lifelong disability. Immature brains are extremely sensitive to HI, shown as prolonged mitochondrial neuronal death. Sodium pyruvate (SP), a substrate of the tricarboxylic acid cycle and an extracellular antioxidant, has been considered as a potential treatment for hypoxic-ischemic encephalopathy, but its effects have not been evaluated in appropriate animal models for hypoxic-ischemic encephalopathy.MethodsThis investigation used primary cortical neuron cultures derived from neonatal rats subjected to oxygen and glucose deprivation (OGD) and a well-established neonatal rat HI model.ResultsHI caused brain tissue loss and impaired sensorimotor function and spatial memory whereas SP significantly reduced brain damage and improved neurological performance. These neuroprotective effects of SP are likely the result of improved cerebral metabolism as demonstrated by maintaining adenosine triphosphate (ATP) levels and preventing an increase in intracellular reactive oxygen species (ROS) levels. SP treatment also decreased levels of Bax, a death signal for immature neurons, blocked caspase-3 activation, and activated a key survival signaling kinase, Akt, both in vitro and in vivo.ConclusionSP protected neonatal brain from hypoxic-ischemic injury through maintaining cerebral metabolism and mitochondrial function.",
author = "Rui Pan and Zhihui Rong and Yun She and Yuan Cao and Chang, {Li Wen} and Lee, {Wei Hua}",
year = "2012",
month = "11",
doi = "10.1038/pr.2012.107",
language = "English",
volume = "72",
pages = "479--489",
journal = "Pediatric Research",
issn = "0031-3998",
publisher = "Lippincott Williams and Wilkins",
number = "5",

}

TY - JOUR

T1 - Sodium pyruvate reduces hypoxic-ischemic injury to neonatal rat brain

AU - Pan, Rui

AU - Rong, Zhihui

AU - She, Yun

AU - Cao, Yuan

AU - Chang, Li Wen

AU - Lee, Wei Hua

PY - 2012/11

Y1 - 2012/11

N2 - BackgroundNeonatal hypoxia-ischemia (HI) remains a major cause of severe brain damage and is often associated with high mortality and lifelong disability. Immature brains are extremely sensitive to HI, shown as prolonged mitochondrial neuronal death. Sodium pyruvate (SP), a substrate of the tricarboxylic acid cycle and an extracellular antioxidant, has been considered as a potential treatment for hypoxic-ischemic encephalopathy, but its effects have not been evaluated in appropriate animal models for hypoxic-ischemic encephalopathy.MethodsThis investigation used primary cortical neuron cultures derived from neonatal rats subjected to oxygen and glucose deprivation (OGD) and a well-established neonatal rat HI model.ResultsHI caused brain tissue loss and impaired sensorimotor function and spatial memory whereas SP significantly reduced brain damage and improved neurological performance. These neuroprotective effects of SP are likely the result of improved cerebral metabolism as demonstrated by maintaining adenosine triphosphate (ATP) levels and preventing an increase in intracellular reactive oxygen species (ROS) levels. SP treatment also decreased levels of Bax, a death signal for immature neurons, blocked caspase-3 activation, and activated a key survival signaling kinase, Akt, both in vitro and in vivo.ConclusionSP protected neonatal brain from hypoxic-ischemic injury through maintaining cerebral metabolism and mitochondrial function.

AB - BackgroundNeonatal hypoxia-ischemia (HI) remains a major cause of severe brain damage and is often associated with high mortality and lifelong disability. Immature brains are extremely sensitive to HI, shown as prolonged mitochondrial neuronal death. Sodium pyruvate (SP), a substrate of the tricarboxylic acid cycle and an extracellular antioxidant, has been considered as a potential treatment for hypoxic-ischemic encephalopathy, but its effects have not been evaluated in appropriate animal models for hypoxic-ischemic encephalopathy.MethodsThis investigation used primary cortical neuron cultures derived from neonatal rats subjected to oxygen and glucose deprivation (OGD) and a well-established neonatal rat HI model.ResultsHI caused brain tissue loss and impaired sensorimotor function and spatial memory whereas SP significantly reduced brain damage and improved neurological performance. These neuroprotective effects of SP are likely the result of improved cerebral metabolism as demonstrated by maintaining adenosine triphosphate (ATP) levels and preventing an increase in intracellular reactive oxygen species (ROS) levels. SP treatment also decreased levels of Bax, a death signal for immature neurons, blocked caspase-3 activation, and activated a key survival signaling kinase, Akt, both in vitro and in vivo.ConclusionSP protected neonatal brain from hypoxic-ischemic injury through maintaining cerebral metabolism and mitochondrial function.

UR - http://www.scopus.com/inward/record.url?scp=84870511720&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84870511720&partnerID=8YFLogxK

U2 - 10.1038/pr.2012.107

DO - 10.1038/pr.2012.107

M3 - Article

C2 - 22885415

AN - SCOPUS:84870511720

VL - 72

SP - 479

EP - 489

JO - Pediatric Research

JF - Pediatric Research

SN - 0031-3998

IS - 5

ER -